Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
Cancer|May 1, 1977
Significance of quantitative assessment of estrogen receptors for endocrine therapy in advanced breast cancerJ C Heuson, E Longeval, W H Mattheiem, et al.Journal of Clinical Pharmacology|January 1, 1978
Double-blind crossover clinical pharmacology study comparing moxestrol (R 2858) and ethinyl estradiol in postmenopausal womenC Robyn, M Vekemans, M Rozencweig, et al.Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.Cancer|August 1, 1978
The chemotherapy of Hodgkin's disease: past experiences and future directionsV T DeVita, B J Lewis, M Rozencweig, et al.Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.European Urology|January 1, 1976
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinomaC C Schulman, M Rozencweig, M Staquet, et al.La Nouvelle Presse Medicale|March 27, 1982
[Clonogenic cultures of human tumours. Experience and prospects in cancer chemotherapy (author's transl)]M Rozencweig, O Makaroff, J M Prevost, et al.Cancer Chemotherapy and Pharmacology|January 1, 1978
The role of antitumor antibiotics in current oncologic practiceH L Davis, D D von Hoff, J E Henney, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Role of antitumor antibiotics in current oncologic practiceH L Davis, D D von Hoff, J E Henney, et al.Archiv Fur Geschwulstforschung|January 1, 1978
Effective adjuvant treatments. A brief review of U.S. clinical trialsA C Louie, M Rozencweig, D D von Hoff, et al.Pageof 13